University of California, Los Angeles Neuro-Oncology : Breakthroughs Magazine

Breakthroughs Magazine

Recent articles related to the creation of more effictive clinical trials and diagnostic......

University of California, Los Angeles Neuro-Oncology : A Comprehensive Brain Tumor Program

Contact Us \| Directions \| Referring a Patient
A leading comprehensive brain tumor program, using molecular diagnostic, gene expression analysis, cutting edge clinical trials and advanced medical informatics to customize treatment plans for cancer patients.

Latest Headlines

•	Attica boy battles brain tumor at WCHOB
	Tue, 21 Feb 2012 15:18:28 -0800
•	Tri-Staters Take an Icy Plunge for Child with Brain Tumor
	Sun, 19 Feb 2012 19:25:47 -0800
•	Researchers make living model of brain tumor
	Thu, 16 Feb 2012 12:34:30 -0800
•	Tyler boy with brain tumor gets help from his school
	Sun, 19 Feb 2012 19:01:24 -0800
•	Brain Tumor Patient To Receive Medical Treatment From Prestigious Doctor
	Thu, 16 Feb 2012 16:24:57 -0800
•	Community to aid boy with brain tumor
	Tue, 21 Feb 2012 15:32:38 -0800
•	GHSU doctor uses rare surgical procedure to remove brain tumor through nose
	Mon, 20 Feb 2012 04:45:58 -0800
•	American Brain Tumor Association Announces “Breakthrough for Brain Tumors” 5K Event
	Thu, 02 Feb 2012 09:46:57 -0800
•	Girl battling brain tumor leaving hospital as family searches for new place to live
	Thu, 16 Feb 2012 21:35:31 -0800
•	Two is Better than One: Combination therapy helps brain tumor patients
	Mon, 13 Feb 2012 20:20:08 -0800

* Headlines are from industry sponsored news wires, medical journals and established news organizations from around the world . Please consider the source of the content when viewing the story.

Improving clinical outcomes in glioblastoma brain tumors with genetic analysis

In this study, featured in the New England Journal of Medicine, glioblastomas patients who were treated with gefitinib or erlotinib, were found to be responsive to EGFR kinase inhibitors and strongly associated with coexpression by the tumor of EGFRvIII and PTEN.

UCLA Neuro-Oncology & SiliconMED Launch Online Tool Correlating Gene Expression Levels with Overall Survival of Brain Cancer Patients

Genomic analysis is a powerful new tool permitting unprecedented insights into how brain tumors form and has been enabled primarily through microarray technology. ProbeSetAnalyzer.com, a new web based tool, is aiming to help clinicians and researchers take the massive amount of data created by microarrays and better visualize gene expression levels and how they relate to the overall survival of brain cancer patients.

12th Annual UCLA Brain Tumor Conference
March 23^rd-24^th 2012

Join brain cancer survivors, family members, friends and health care professionals at the 2010 UCLA Brain Tumor Conference, hosted by the UCLA Neuro-Oncology Program.

This FREE conference will offer participants the opportunity to hear leading healthcare professionals speak about the latest treatments for brain tumors. Through this conference, the Neuro-Oncology Program promotes the sharing of information and experience between brain tumor survivors, their families, friends and health care professionals.

• PARKING INFORMATION!
• Conference Schedule • Registration: Sign Up

At the 2012 Conference: Dr. Carolyn Katzin:

In her 1 hour lecture, Dr. Katzin helps explain the importance of nutrition in a comprehensive treatment plan.

She also will help us interpret how to use this knowledge in a positive way rather than simply talk about disease risk

Visit Dr Carolyn Katzin online resources for more information about the Cancer Nutrition Center Handbook, The DNA Diet, and personalized nutrition plans.

Dani Saleh Brain Cancer Research Fund at UCLA

The Dani Saleh Brain Cancer Research Fund supports the brain cancer research collaboration between Dr. Timothy Cloughesy and Dr. Stan Nelson. This fund will directly support the work and training of a research fellow in Dr. Stan Nelson’s lab.

Dr. Nelson is Professor and Vice Chair of Human Genetics and Professor of Psychiatry at the David Geffen School of Medicine at UCLA.

Most Popular

.	Clinical Trials
.	Probe Set Analyzer
.	Our Team
.	Brain Tumor Translational Resource
.	Art of the Brain
.	Personalized Medicine using Targeted Molecular Therapy
.	Online Giving
.	How our Glioblastoma Multiforme Patients Perform
	Neuro-Oncology on Facebook

Breakthroughs Magazine


	Spring / Summer 2012 Breakthroughs

View All Issues

Recent Publications


	It is time to include patients with brain tumors in phase I trials in oncology. J Clin Oncol.

	Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumab. Neuro Oncol.

	Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma. Neuro Oncol.

	Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery. J Neurooncol.

	Phase II study of aflibercept in recurrent malignant glioma: a north american brain tumor consortium study. J Clin Oncol.

View All Articles

All Information content hearof is designed for educational purposes only and is not for the purpose of rendering medical advice or professional services. The information provided should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. Any specific questions you may have regarding an individual's medical condition should be directed to the individual's primary care physician or other attending physician. In addition, if you have or suspect you may have a health problem, you should consult your health care provider.

Portions Copyright (Search, Chart, Content Publishing Tools, Photography, Provider^IQ) 1998-2012 SiliconMED North America

Provider^IQ is a registered trademark of SiliconMED North America and used by permission.

[Content Published:2/22/2012 4:47:44 AM PST]